Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)

Market Cap	12.63B
Revenue (ttm)	2.38B
Net Income (ttm)	553.70M
Shares Out	530.94M
EPS (ttm)	1.04
PE Ratio	22.78
Forward PE	n/a
Dividend	0.48 (2.02%)
Ex-Dividend Date	Jan 24, 2025

Volume	1,069,400
Average Volume	3,692,108
Open	24.02
Previous Close	23.82
Day's Range	23.64 - 24.02
52-Week Range	18.07 - 26.39
Beta	0.77
RSI	54.74
Earnings Date	Apr 25, 2025

About SHE:002287

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China. It provides products in the areas of orthopedics, neurology, dermatology, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, and cerebrovascular sectors. The company was founded in 1995 and is based in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. is a subsidiary of Gansu Qizheng Industry Group Co., Ltd.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 3,091
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002287

Financial Performance

In 2024, SHE:002287's revenue was 2.34 billion, an increase of 14.32% compared to the previous year's 2.05 billion. Earnings were 582.28 million, an increase of 0.19%.